Brussels – On 7 April 2021, the European Alliance for Access to Safe Medicines (EAASM)published its report ‘Patient Safety and the Implementation of the Falsified
EU Parliament virtual roundtable30 November 2020 Event summary On Monday 30th November, the European Alliance for Access to Safe medicines (EAASM) organised an online event
On behalf of the European Alliance for Access to Safe Medicines, you are kindly invited to join the upcoming virtual roundtable event on “Innovation in
Event summary of “Patient safety and the implementation of the Falsified Medicines Directive (FMD) in the hospital environment” held as a live webinar on 30th
Led by MEP Manuel Pizarro (S&D) this live webinar will be especially useful for hospital pharmacists and their teams across the EU. Following the entry
Commission urged to consider common regulatory framework for nanomedicines” supports the EAASM goals for nanomedicines and nanosimilars for regulatory clarity The lack of a fit-for-purpose
Brussels, 17 September 2020 – On World Patient Safety Day 2020, the European Alliance for Access to Safe Medicines along with several organisations launches its
BACKGROUND: Pharmaceutical compounding allows individuals with special requirements access to medicines. Compounding can also be used to provide cheaper alternatives to commercially produced medicines which
The European Alliance for Access to Safe Medicines (EAASM) in collaboration with the European Union of Private Hospitals (UEHP) and the European Health Management Association
ASOP EU-EAASM Spring 2019 Newsletter